SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-050871
Filing Date
2007-03-09
Accepted
2007-03-09 16:02:27
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 911160
2 DESCRIPTION OF EXECUTIVE OFFICER ANNUAL INCENTIVE CASH COMPENSATION PROGRAM dex1026.htm EX-10.26 2451
3 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1975
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1864
5 CERTIFICATION OF ULI HACKSELL, PH.D., CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6777
6 CERTIFICATION OF THOMAS H. ASEN, CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6750
7 CERTIFICATION OF ULI HACKSELL, PH.D., CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3685
8 CERTIFICATION OF THOMAS H. AASEN, CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3825
  Complete submission text file 0001193125-07-050871.txt   939888
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50768 | Film No.: 07684560
SIC: 2834 Pharmaceutical Preparations